Three High-Growth Companies With Significant Insider Ownership

In a week marked by mixed returns and sector rotations, the global markets have shown both resilience and volatility. As investors navigate these uncertain waters, identifying growth companies with significant insider ownership can provide a strategic edge. High insider ownership often signals confidence in the company's future prospects, aligning management's interests with those of shareholders. In this article, we will explore three high-growth companies where insiders hold substantial stakes, potentially offering robust opportunities amidst current market dynamics.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Cettire (ASX:CTT)	28.7%	26.7%
Gaming Innovation Group (OB:GIG)	26.7%	37.4%
Clinuvel Pharmaceuticals (ASX:CUV)	13.6%	26.8%
KebNi (OM:KEBNI B)	37.8%	90.4%
Credo Technology Group Holding (NasdaqGS:CRDO)	14.4%	60.9%
Calliditas Therapeutics (OM:CALTX)	11.6%	52.9%
Vow (OB:VOW)	31.7%	97.7%
UTI (KOSDAQ:A179900)	33.1%	122.7%
Adocia (ENXTPA:ADOC)	11.9%	63%
HANA Micron (KOSDAQ:A067310)	20%	97.4%

Click here to see the full list of 1455 stocks from our Fast Growing Companies With High Insider Ownership screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Aspen Pharmacare Holdings (JSE:APN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Aspen Pharmacare Holdings Limited, with a market cap of ZAR112.06 billion, manufactures and supplies specialty and branded pharmaceutical products globally through its subsidiaries.

Operations: Aspen Pharmacare generates revenue from its manufacturing segment, which contributed ZAR12.81 billion, with an additional segment adjustment of ZAR29.89 billion.

Insider Ownership: 17.2%

Aspen Pharmacare Holdings is projected to see robust earnings growth of 27.73% per year, significantly outpacing the ZA market's 19.3%. The company's revenue is also expected to grow at 10.2% annually, faster than the market average of 3.4%, although not exceptionally high. Trading at a substantial discount of 44.2% below its estimated fair value, Aspen offers potential upside despite a forecasted low Return on Equity of 9.4% in three years and no recent insider trading activity reported over the past three months.

• Click to explore a detailed breakdown of our findings in Aspen Pharmacare Holdings' earnings growth report.
• Our valuation report here indicates Aspen Pharmacare Holdings may be undervalued.

BIWIN Storage Technology (SHSE:688525)

Simply Wall St Growth Rating: ★★★★★☆

Overview: BIWIN Storage Technology Co., Ltd. engages in the research, development, design, packaging, testing, production, and sale of semiconductor memories with a market cap of CN¥23.87 billion.

Operations: BIWIN Storage Technology generates revenue primarily from its semiconductor segment, which amounted to CN¥4.89 billion.

Insider Ownership: 18.8%

BIWIN Storage Technology is forecasted to grow earnings by 121.67% annually, with revenue expected to increase by 25.6% per year, outpacing the CN market's growth rate of 13.7%. Despite a highly volatile share price over the past three months and a low projected Return on Equity of 19.7%, BIWIN is anticipated to become profitable within three years. Recent developments include launching new consumer storage products and completing a CNY 20 million share buyback program in June 2024.

• Unlock comprehensive insights into our analysis of BIWIN Storage Technology stock in this growth report.
• Our valuation report here indicates BIWIN Storage Technology may be overvalued.

Eoptolink Technology (SZSE:300502)

Simply Wall St Growth Rating: ★★★★★★

Overview: Eoptolink Technology Inc., Ltd. specializes in the research, development, manufacture, and sale of optical transceivers both in China and internationally, with a market cap of CN¥70.72 billion.

Operations: The company's revenue primarily comes from its Optical Communication Equipment segment, which generated CN¥3.61 billion.

Insider Ownership: 26.7%

Eoptolink Technology Inc., Ltd. is forecast to achieve significant earnings growth of 39.4% annually over the next three years, outpacing the CN market's 22.2%. Revenue is expected to grow at an impressive rate of 41.2% per year, well above the market average of 13.7%. Despite a highly volatile share price recently, Eoptolink's Return on Equity is projected to reach a robust 25.7%, with no substantial insider trading activity reported in the last three months.

• Click here to discover the nuances of Eoptolink Technology with our detailed analytical future growth report.
• In light of our recent valuation report, it seems possible that Eoptolink Technology is trading beyond its estimated value.

Summing It All Up

• Dive into all 1455 of the Fast Growing Companies With High Insider Ownership we have identified here.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.

Contemplating Other Strategies?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com